230 related articles for article (PubMed ID: 29781137)
1. Variants in ACTG2 underlie a substantial number of Australasian patients with primary chronic intestinal pseudo-obstruction.
Ravenscroft G; Pannell S; O'Grady G; Ong R; Ee HC; Faiz F; Marns L; Goel H; Kumarasinghe P; Sollis E; Sivadorai P; Wilson M; Magoffin A; Nightingale S; Freckmann ML; Kirk EP; Sachdev R; Lemberg DA; Delatycki MB; Kamm MA; Basnayake C; Lamont PJ; Amor DJ; Jones K; Schilperoort J; Davis MR; Laing NG
Neurogastroenterol Motil; 2018 Sep; 30(9):e13371. PubMed ID: 29781137
[TBL] [Abstract][Full Text] [Related]
2. Recurrent arginine substitutions in the ACTG2 gene are the primary driver of disease burden and severity in visceral myopathy.
Assia Batzir N; Kishor Bhagwat P; Larson A; Coban Akdemir Z; Bagłaj M; Bofferding L; Bosanko KB; Bouassida S; Callewaert B; Cannon A; Enchautegui Colon Y; Garnica AD; Harr MH; Heck S; Hurst ACE; Jhangiani SN; Isidor B; Littlejohn RO; Liu P; Magoulas P; Mar Fan H; Marom R; McLean S; Nezarati MM; Nugent KM; Petersen MB; Rocha ML; Roeder E; Smigiel R; Tully I; Weisfeld-Adams J; Wells KO; ; Posey JE; Lupski JR; Beaudet AL; Wangler MF
Hum Mutat; 2020 Mar; 41(3):641-654. PubMed ID: 31769566
[TBL] [Abstract][Full Text] [Related]
3. Visceral myopathy: Clinical and molecular survey of a cohort of seven new patients and state of the art of overlapping phenotypes.
Moreno CA; Metze K; Lomazi EA; Bertola DR; Barbosa RH; Cosentino V; Sobreira N; Cavalcanti DP
Am J Med Genet A; 2016 Nov; 170(11):2965-2974. PubMed ID: 27481187
[TBL] [Abstract][Full Text] [Related]
4. Novel ACTG2 variants disclose allelic heterogeneity and bi-allelic inheritance in pediatric chronic intestinal pseudo-obstruction.
Matera I; Bordo D; Di Duca M; Lerone M; Santamaria G; Pongiglione M; Lezo A; Diamanti A; Spagnuolo MI; Pini Prato A; Alberti D; Mattioli G; Gandullia P; Ceccherini I
Clin Genet; 2021 Mar; 99(3):430-436. PubMed ID: 33294969
[TBL] [Abstract][Full Text] [Related]
5. Variants of the ACTG2 gene correlate with degree of severity and presence of megacystis in chronic intestinal pseudo-obstruction.
Matera I; Rusmini M; Guo Y; Lerone M; Li J; Zhang J; Di Duca M; Nozza P; Mosconi M; Pini Prato A; Martucciello G; Barabino A; Morandi F; De Giorgio R; Stanghellini V; Ravazzolo R; Devoto M; Hakonarson H; Ceccherini I
Eur J Hum Genet; 2016 Aug; 24(8):1211-5. PubMed ID: 26813947
[TBL] [Abstract][Full Text] [Related]
6. Segregation of a missense variant in enteric smooth muscle actin γ-2 with autosomal dominant familial visceral myopathy.
Lehtonen HJ; Sipponen T; Tojkander S; Karikoski R; Järvinen H; Laing NG; Lappalainen P; Aaltonen LA; Tuupanen S
Gastroenterology; 2012 Dec; 143(6):1482-1491.e3. PubMed ID: 22960657
[TBL] [Abstract][Full Text] [Related]
7. New Insights into the Genetics of Fetal Megacystis: ACTG2 Mutations, Encoding γ-2 Smooth Muscle Actin in Megacystis Microcolon Intestinal Hypoperistalsis Syndrome (Berdon Syndrome).
Tuzovic L; Tang S; Miller RS; Rohena L; Shahmirzadi L; Gonzalez K; Li X; LeDuc CA; Guo J; Wilson A; Mills A; Glassberg K; Rotterdam H; Sepulveda AR; Zeng W; Chung WK; Anyane-Yeboa K
Fetal Diagn Ther; 2015; 38(4):296-306. PubMed ID: 25998219
[TBL] [Abstract][Full Text] [Related]
8. Heterozygous de novo and inherited mutations in the smooth muscle actin (ACTG2) gene underlie megacystis-microcolon-intestinal hypoperistalsis syndrome.
Wangler MF; Gonzaga-Jauregui C; Gambin T; Penney S; Moss T; Chopra A; Probst FJ; Xia F; Yang Y; Werlin S; Eglite I; Kornejeva L; Bacino CA; Baldridge D; Neul J; Lehman EL; Larson A; Beuten J; Muzny DM; Jhangiani S; ; Gibbs RA; Lupski JR; Beaudet A
PLoS Genet; 2014 Mar; 10(3):e1004258. PubMed ID: 24676022
[TBL] [Abstract][Full Text] [Related]
9. ACTG2-Associated Visceral Myopathy With Chronic Intestinal Pseudoobstruction, Intestinal Malrotation, Hypertrophic Pyloric Stenosis, Choledochal Cyst, and a Novel Missense Mutation.
Collins RRJ; Barth B; Megison S; Pfeifer CM; Rice LM; Harris S; Timmons CF; Rakheja D
Int J Surg Pathol; 2019 Feb; 27(1):77-83. PubMed ID: 30019982
[TBL] [Abstract][Full Text] [Related]
10. Use of whole genome sequencing to determine the genetic basis of visceral myopathies including Prune Belly syndrome.
Geraghty RM; Orr S; Olinger E; Neatu R; Barroso-Gil M; Mabillard H; Consortium GER; Wilson I; Sayer JA
J Rare Dis (Berlin); 2023; 2(1):9. PubMed ID: 37288276
[TBL] [Abstract][Full Text] [Related]
11.
Hahn JW; Moon SY; Kim MS; Woo MH; Sohn MJ; Kim HY; Seong MW; Park SS; Park SH; Moon JS; Ko JS
J Neurogastroenterol Motil; 2022 Jan; 28(1):104-110. PubMed ID: 34980693
[TBL] [Abstract][Full Text] [Related]
12. Smooth muscle motility disorder phenotypes: A systematic review of cases associated with seven pathogenic genes (
Fournier N; Fabre A
Intractable Rare Dis Res; 2022 Aug; 11(3):113-119. PubMed ID: 36200034
[TBL] [Abstract][Full Text] [Related]
13. Visceral myopathy diagnosed by a de novo
Xiong X; Li J; Liu C; Xu F
Transl Pediatr; 2021 Mar; 10(3):679-685. PubMed ID: 33880338
[TBL] [Abstract][Full Text] [Related]
14. ACTG2 variants impair actin polymerization in sporadic Megacystis Microcolon Intestinal Hypoperistalsis Syndrome.
Halim D; Hofstra RM; Signorile L; Verdijk RM; van der Werf CS; Sribudiani Y; Brouwer RW; van IJcken WF; Dahl N; Verheij JB; Baumann C; Kerner J; van Bever Y; Galjart N; Wijnen RM; Tibboel D; Burns AJ; Muller F; Brooks AS; Alves MM
Hum Mol Genet; 2016 Feb; 25(3):571-83. PubMed ID: 26647307
[TBL] [Abstract][Full Text] [Related]
15. Loss of LMOD1 impairs smooth muscle cytocontractility and causes megacystis microcolon intestinal hypoperistalsis syndrome in humans and mice.
Halim D; Wilson MP; Oliver D; Brosens E; Verheij JB; Han Y; Nanda V; Lyu Q; Doukas M; Stoop H; Brouwer RW; van IJcken WF; Slivano OJ; Burns AJ; Christie CK; de Mesy Bentley KL; Brooks AS; Tibboel D; Xu S; Jin ZG; Djuwantono T; Yan W; Alves MM; Hofstra RM; Miano JM
Proc Natl Acad Sci U S A; 2017 Mar; 114(13):E2739-E2747. PubMed ID: 28292896
[TBL] [Abstract][Full Text] [Related]
16. Intestinal Pathology in Patients With Pathogenic
Kapur RP; Goldstein AM; Loeff DS; Myers CT; Paschal CR
Pediatr Dev Pathol; 2022; 25(6):581-597. PubMed ID: 35695198
[TBL] [Abstract][Full Text] [Related]
17. Compound heterozygous loss of function variants in MYL9 in a child with megacystis-microcolon-intestinal hypoperistalsis syndrome.
Kandler JL; Sklirou E; Woerner A; Walsh L; Cox E; Xue Y
Mol Genet Genomic Med; 2020 Nov; 8(11):e1516. PubMed ID: 33031641
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic expansion of visceral myopathy associated with ACTG2 tandem base substitution.
Klar J; Raykova D; Gustafson E; Tóthová I; Ameur A; Wanders A; Dahl N
Eur J Hum Genet; 2015 Dec; 23(12):1679-83. PubMed ID: 25782675
[TBL] [Abstract][Full Text] [Related]
19. Identification of a dominant MYH11 causal variant in chronic intestinal pseudo-obstruction: Results of whole-exome sequencing.
Dong W; Baldwin C; Choi J; Milunsky JM; Zhang J; Bilguvar K; Lifton RP; Milunsky A
Clin Genet; 2019 Nov; 96(5):473-477. PubMed ID: 31389005
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
